Skip to content
Search

Latest Stories

DHSC creates new NIHR Research Delivery Network

DHSC New NIHR RDN
This additional funding follows the success of the NIHR-funded projects in the past. Photo: iStock

Growing the amount of commercial clinical research will be a key strategic ambition for the new network 

The Department of Health and Social Care (DHSC) has created a new NIHR Research Delivery Network (RDN) to support the successful delivery of health and social care research in England.


The network, which will start operating from next year, will play a critical and active role in implementing government policies.

It will support in implementing the Life Sciences Vision, the Future of UK Clinical Research Delivery vision, and policy for life sciences research and development.

The new network would be mainly working on growing the amount of commercial clinical research as its key strategic ambition.

Also, NIHR RDN will be responding to the findings of the Lord O’Shaughnessy review, which set out a clear blueprint for how the UK can return to its global leadership role.

The DHSC’s statement read: “It will increase capacity and capability across the health and care research system, supporting the successful delivery of high-quality research across England for the benefit of patients and the public.

“It represents a significant government investment to bolster the UK’s position as one of the best places in the world for innovative companies and investigators to carry out research.”

Along with portfolio monitoring, the network will focus on identifying and resolving strategic challenges to ensure the research system is able to achieve its ambitions around innovative study methodology.

The new network will provide funding to study sites and ensure that it is being used to support research and development activities.

As a new organisation, the NIHR RDN will have new processes, structures and governance, and will work across the health and care system, with staff in all health and care settings.

It will work across the health and care system, with staff in all health and care settings, to support the effective and efficient initiation and delivery of research.

The University of Leeds will be the single host of the new NIHR RDN Co-ordinating Centre (RDNCC) from 1 April 2024.

From October 2024, they will be joined by 12 Regional Research Delivery Networks (RRDNs), hosted by NHS organisations across the country, to make up the NIHR RDN.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less